Company / Cash & Equivalents
ESTABLISHMENT LABS HOLDINGS INC. Cash & Equivalents History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$75.6M
FY2025
5-year range
$40.0M / $90.3M
FY2021-FY2025
Trend
-16.4%
vs FY2024
Sector context
#121 of 148
Health Care
What the data says
ESTABLISHMENT LABS HOLDINGS INC.'s cash & equivalents of $76M is lower than 82% of companies in the Health Care sector (FY2025). Cash & Equivalents has fluctuated over the past 5 years, ranging from $11M in FY2017 to $90M in FY2024.
Based on SEC 10-K filings.
$76M in FY2025 with a 3-year CAGR of +4.4%.
Improved from $40M to $76M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +4.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 148This company $75.6M Sector average $1.2B
▼
-93.6% below sector average
Key checks
Key Insights
- 3-year CAGR of +4.4%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 16.4% year-over-year.
- Ranks #121 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.56 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $75.6M | -16.4% |
| FY2024 | $90.3M | +125.7% |
| FY2023 | $40.0M | -39.7% |
| FY2022 | $66.4M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $10.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026